retatrutide triple agonist glp1 gip glucagon The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide: How the Triple Agonist
Description
Why patients love it: Some people say they barely feel the needle here, making it a reassuring backup when the abdomen or thigh feels tender
The platform provides aggregated data from inpatient and outpatient clinical encounters including demographics, diagnoses, procedures, medications, laboratory tests, and genomic information
Spot an error
However, its physiological effects may persist longer because it influences hormone signaling and metabolic regulation
Edwards LL, Pfeiffer RF, Quigley EM, Hofman R, Balluff M
Wilmington, DE: AstraZeneca Pharmaceuticals LP;2018
